- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 27.01. | Emotive appoints Terri Cooper and Mark Swindell in senior roles | ||
| 26.01. | Eisai and Biogen's subcutaneous Leqembi given FDA Priority Review for early Alzheimer's | ||
| 26.01. | Gilead's Trodelvy plus Keytruda shows positive results in metastatic breast cancer | ||
| 23.01. | Sanofi's amlitelimab shows positive results in atopic dermatitis | ||
| 23.01. | Inizio Evoke appoints Kristin Ryan as Executive VP, AI Transformation & Acceleration | ||
| 22.01. | Novo Nordisk Foundation gives 736m euro grant to Denmark's BioInnovation Institute | ||
| 22.01. | Book your tickets and join the PM Society for the 40th PM Awards on 20 March 2026 | ||
| 22.01. | Inizio Ignite sparks a new era of connected advisory solutions | ||
| 21.01. | PMGroup Worldwide welcomes MAD World Summit | ||
| 21.01. | Moderna and Merck announce data from melanoma combination therapy study | ||
| 21.01. | Prescient Healthcare Group acquires Uptake | ||
| 20.01. | Skin Health Alliance donates funds to British Skin Foundation to drive research | ||
| 20.01. | smartbax licenses compound from Aicuris for next-generation antibiotic development | ||
| 19.01. | Novartis' ianalumab receives FDA Breakthrough Therapy designation for Sjögren's disease | ||
| 19.01. | DEBRA Research and University Medical Center Groningen launch clinical trial site for epidermolysis bullosa | ||
| 16.01. | Vibrant Therapeutics raises $61m in funding to advance intelligent therapeutics pipeline | ||
| 16.01. | Vibrant Therapeutics appoints Han Lee as co-CEO | ||
| 16.01. | From patients to consumers: why pharma communications must rethink the rules of engagement | ||
| 15.01. | Takeda's zasocitinib demonstrates positive results in plaque psoriasis | ||
| 15.01. | NanoSyrinx appoints Thomas J Farrell as CEO | ||
| 14.01. | VML Health appoints Nadine Leonard as Global Chief Solutions & Innovation Officer | ||
| 14.01. | AbbVie reaches agreement for affordable prescription drugs with US government | ||
| 13.01. | Novo Nordisk's Wegovy higher dose injection approved by UK MHRA for obesity | ||
| 13.01. | Enhanced Genomics appoints Katerina Leftheris to Board of Directors | ||
| 12.01. | Johnson & Johnson's Rybrevant shows positive effects in difficult-to-treat colorectal cancer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.